176 related articles for article (PubMed ID: 9069478)
1. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
Federico F; Simone IL; Lucivero V; De Mari M; Giannini P; Iliceto G; Mezzapesa DM; Lamberti P
J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):239-42. PubMed ID: 9069478
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
Federico F; Simone IL; Lucivero V; Mezzapesa DM; de Mari M; Lamberti P; Petruzzellis M; Ferrari E
Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908
[TBL] [Abstract][Full Text] [Related]
5. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR
Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
[TBL] [Abstract][Full Text] [Related]
6. MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms.
Zheng XN; Zhu XC; Ruan LX; Zhang LJ; Yuan M; Shang DS; Liu Y
J Zhejiang Univ Sci; 2004 Feb; 5(2):246-50. PubMed ID: 14674041
[TBL] [Abstract][Full Text] [Related]
7. Detection and application of neurochemical profile by multiple regional
Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
[TBL] [Abstract][Full Text] [Related]
8. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
Cruz CJ; Aminoff MJ; Meyerhoff DJ; Graham SH; Weiner MW
Magn Reson Imaging; 1997; 15(6):619-24. PubMed ID: 9285801
[TBL] [Abstract][Full Text] [Related]
9. Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.
Choe BY; Park JW; Lee KS; Son BC; Kim MC; Kim BS; Suh TS; Lee HK; Shinn KS
Invest Radiol; 1998 Aug; 33(8):450-5. PubMed ID: 9704284
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy in idiopathic spasmodic torticollis.
Federico F; Lucivero V; Simone IL; Defazio G; De Salvia R; Mezzapesa DM; Petruzzellis M; Tortorella C; Livrea P
Neuroradiology; 2001 Jul; 43(7):532-6. PubMed ID: 11512580
[TBL] [Abstract][Full Text] [Related]
11. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Guevara CA; Blain CR; Stahl D; Lythgoe DJ; Leigh PN; Barker GJ
Eur J Neurol; 2010 Sep; 17(9):1193-1202. PubMed ID: 20402762
[TBL] [Abstract][Full Text] [Related]
12. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ
Metab Brain Dis; 1999 Mar; 14(1):45-55. PubMed ID: 10348313
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome.
Davie CA; Barker GJ; Machado C; Miller DH; Lees AJ
Mov Disord; 1997 Sep; 12(5):767-71. PubMed ID: 9380064
[TBL] [Abstract][Full Text] [Related]
14. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.
Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C
Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopic study of parkinsonism related to boxing.
Davie CA; Pirtosek Z; Barker GJ; Kingsley DP; Miller PH; Lees AJ
J Neurol Neurosurg Psychiatry; 1995 Jun; 58(6):688-91. PubMed ID: 7608666
[TBL] [Abstract][Full Text] [Related]
16. Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.
Baik HM; Choe BY; Son BC; Jeun SS; Kim MC; Lee KS; Kim BS; Lee JM; Lee HK; Suh TS
Eur J Radiol; 2003 Sep; 47(3):179-87. PubMed ID: 12927660
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
Lucetti C; Del Dotto P; Gambaccini G; Bernardini S; Bianchi MC; Tosetti M; Bonuccelli U
Neurol Sci; 2001 Feb; 22(1):69-70. PubMed ID: 11487206
[TBL] [Abstract][Full Text] [Related]
18. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy of adult-onset dentatorubral-pallidoluysian atrophy.
Kin T; Hirano M; Taoka T; Takamure M; Furiya Y; Kichikawa K; Ueno S
Magn Reson Med Sci; 2005; 4(3):123-7. PubMed ID: 16462132
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
Davie CA; Wenning GK; Barker GJ; Tofts PS; Kendall BE; Quinn N; McDonald WI; Marsden CD; Miller DH
Ann Neurol; 1995 Feb; 37(2):204-10. PubMed ID: 7847862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
